Drug Safety Clinical Trials

• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00440973 - Active, not recruiting
  Carcinoma, Renal Cell
  
• To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug
  ClinicalTrials.gov Identifier: NCT00436228 - Active, not recruiting
  Healthy
  
• A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00296569 - Active, not recruiting
  Osteoarthritis
  
• Emergency Pharmacist Safety Study
  ClinicalTrials.gov Identifier: NCT00382434 - Recruiting
  Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures
  
• Safety and Tolerability Study of Drug to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044005 - Active, not recruiting
  Schizophrenia
  
• Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00116129 - Active, not recruiting
  Fibromyalgia
  
• A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain
  ClinicalTrials.gov Identifier: NCT00410644 - Active, not recruiting
  Opioid; Analgesics; Pain
  
• A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
  ClinicalTrials.gov Identifier: NCT00411034 - Active, not recruiting
  Analgesics, Opioid; Pain
  
• A Study to Evaluate the Safety and Efficacy of an Investigational Drug in the Treatment of Postoperative Dental Pain
  ClinicalTrials.gov Identifier: NCT00387140 - Active, not recruiting
  Pain, Postoperative; Tooth Extraction
  
• Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid
  ClinicalTrials.gov Identifier: NCT00333684 - Active, not recruiting
  Human Immunodeficiency Virus; Facial Lipoatrophy
  
• A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
  ClinicalTrials.gov Identifier: NCT00044135 - Active, not recruiting
  Hepatitis B
  
• A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00423410 - Active, not recruiting
  Advanced Cancer
  
• Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
  ClinicalTrials.gov Identifier: NCT00002241 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
  ClinicalTrials.gov Identifier: NCT00007202 - Active, not recruiting
  HIV Infections
  
• Efficacy and Safety of an Investigational Drug for Insomnia in Adults
  ClinicalTrials.gov Identifier: NCT00095069 - Active, not recruiting
  Insomnia
  
• Improving Geriatric Drug Safety in Underserved Practices
  ClinicalTrials.gov Identifier: NCT00277173 - Recruiting
  Cardiovascular Diseases
  
• Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
  ClinicalTrials.gov Identifier: NCT00027339 - Active, not recruiting
  HIV Infections
  
• Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00223951 - Active, not recruiting
  Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
  
• Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)
  ClinicalTrials.gov Identifier: NCT00239915 - Active, not recruiting
  Persistent Developmental Stuttering
  
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
  ClinicalTrials.gov Identifier: NCT00050895 - Active, not recruiting
  HIV Infections
  
• Efficacy and Safety In Poorly Controlled Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00044460 - Active, not recruiting
  type 2 diabetes
  
• A Study to Assess the Efficacy, Safety, and Tolerability of a Novel Investigational Drug in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00132769 - Active, not recruiting
  Rheumatoid Arthritis
  
• Brief Intervention for Prescription Drug Misuse in General Hospital
  ClinicalTrials.gov Identifier: NCT00514839 - Active, not recruiting
  Abuse of Prescription Drug; Dependence on Prescription Drugs; Regular Consumption of Prescription Drug
  
• Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment
  ClinicalTrials.gov Identifier: NCT00450216 - Recruiting
  Ulcer
  
• Safety of AMD11070, a New Anti-HIV Drug, in HIV Uninfected Men
  ClinicalTrials.gov Identifier: NCT00063804 - Active, not recruiting
  HIV Infections
  
• An Eighteen Month Efficacy and Safety Study in Obese Patients
  ClinicalTrials.gov Identifier: NCT00131430 - Active, not recruiting
  Obesity and obesity-related medical conditions
  
• A research study in patients with moderate to severe rheumatoid arthritis to observe the safety and effectiveness of MRA (investigational drug) combined with methotrexate compared to placebo combined with methotrexate
  ClinicalTrials.gov Identifier: NCT00106548 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product
  ClinicalTrials.gov Identifier: NCT00471224 - Recruiting
  Siderosis
  
• Study to Evaluate Drug-Drug Interaction Between Valopicitabine and Ribavirin
  ClinicalTrials.gov Identifier: NCT00395421 - Active, not recruiting
  Chronic Hepatitis C
  
• To study the safety of and ability of MRA, an investigational drug, in reducing the signs and symptoms of rheumatoid arthritis in combination with DMARD therapy as compared to placebo in combination with DMARD therapy
  ClinicalTrials.gov Identifier: NCT00106574 - Active, not recruiting
  Rheumatoid Arthritis
  
• Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug
  ClinicalTrials.gov Identifier: NCT00472836 - Recruiting
  Obesity; Renal Insufficiency
  
• Safety and Efficacy of an Investigational Drug in HIV-infected Patients Failing Current Antiretroviral Therapies
  ClinicalTrials.gov Identifier: NCT00105157 - Active, not recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00100048 - Active, not recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000944 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Drug Facts Page or a Short Drug Summary in Helping Patients and Doctors Understand Medical Information
  ClinicalTrials.gov Identifier: NCT00450931 - Active, not recruiting
  Health Status Unknown
  
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents
  ClinicalTrials.gov Identifier: NCT00075907 - Active, not recruiting
  HIV Infections
  
• A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
  ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
  Hypertension
  
• Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00414518 - Recruiting
  HIV Infections
  
• Safety and Effectiveness of the Drug DPC 083 in Combination with Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment with Nonnucleoside Reverse Transcriptase Inhibitors
  ClinicalTrials.gov Identifier: NCT00007449 - Active, not recruiting
  HIV Infections
  
• Improving Pediatric Safety and Quality with Health Care Information Technology
  ClinicalTrials.gov Identifier: NCT00134823 - Active, not recruiting
  MEDICATION ERRORS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PATIENT SAFETY; QUALITY IMPROVEMENT
  
• Randomized, Open-Label, Comparative Safety and Efficacy Study of Tipranavir Boosted with Low-Dose Ritonavir (TPV/RTV) Versus Genotypically-Defined Protease Inhibitor/Ritonavir (PI/RTV) in Multiple Antiretroviral Drug-Experienced Patients (RESIST 2)
  ClinicalTrials.gov Identifier: NCT00144170 - Active, not recruiting
  HIV Infections
  
• A Two Year Safety and Efficacy Study in Obese Patients
  ClinicalTrials.gov Identifier: NCT00131404 - Active, not recruiting
  Obesity and obesity-related medical conditions
  
• Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00383578 - Recruiting
  Diabetes Mellitus, Type 2
  
• Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter
  ClinicalTrials.gov Identifier: NCT00454220 - Recruiting
  Multinodular Goiter
  
• Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers
  ClinicalTrials.gov Identifier: NCT00389792 - Recruiting
  Atrial Fibrillation
  
• A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-Valvular Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00504556 - Recruiting
  Atrial Fibrillation; Thromboembolism
  
• Employment-Based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction - 1
  ClinicalTrials.gov Identifier: NCT00249470 - Active, not recruiting
  Cocaine; Cocaine Abuse; Contingency Management; HIV; HIV Risk Behaviors; Heroin; Heroin Dependence; Methadone; Opioid Dependence; Substance Abuse, Intravenous; Alcohol & Drug Use; Sexual Risk Behaviors
  
• TMC207-TiDP13-C208: Anti-Bacterial Activity, Safety, and Tolerability of TMC207 in Patients With Multi-Drug Resistant Mycobacterium Tuberculosis (MDR-TB).
  ClinicalTrials.gov Identifier: NCT00449644 - Recruiting
  Tuberculosis
  
• ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)
  ClinicalTrials.gov Identifier: NCT00041509 - Active, not recruiting
  Thromboembolism; Deep Vein Thrombosis; Venous Thromboembolism; Pulmonary Embolism
  
• Preventing Adverse Drug Events with PatientSite
  ClinicalTrials.gov Identifier: NCT00140504 - Active, not recruiting
  Preventive health; Primary care; Adverse drug event
  
• One Year Drug Treatment in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
  Schizophrenia
  
• Safety and Efficacy Study in Acute Ischaemic Stroke
  ClinicalTrials.gov Identifier: NCT00144014 - Recruiting
  Stroke
  
• A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00308282 - Recruiting
  Rheumatoid Arthritis
  
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor
  ClinicalTrials.gov Identifier: NCT00041769 - Active, not recruiting
  HIV Infections
  
• Employment-Based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2
  ClinicalTrials.gov Identifier: NCT00249457 - Active, not recruiting
  Behavior Therapy; Cocaine Abuse; Cocaine Dependence; Contingency Management; Heroin Dependence; Methadone; Opioid Dependence
  
• Clinical Trial to Test the Safety and Effectiveness of an Investigational Drug CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00522938 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00024427 - Active, not recruiting
  adenocarcinoma of the pancreas; Drug Toxicity; Pancreatic Cancer
  
• Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00234910 - Active, not recruiting
  HIV Infection
  
• An Investigational Drug Study in Obese (considerably overweight) Patients
  ClinicalTrials.gov Identifier: NCT00109148 - Active, not recruiting
  Obesity
  
• Improving Hepatitis C Treatment in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00148031 - Recruiting
  Hepatitis C; Intravenous Drug Abuse; Liver Diseases; Drug Abuse; Alcoholism
  
• One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
  ClinicalTrials.gov Identifier: NCT00142337 - Active, not recruiting
  HIV; Postpartum Period
  
• CSP #512 - Options in Management with Anti-Retrovirals (OPTIMA)
  ClinicalTrials.gov Identifier: NCT00050089 - Active, not recruiting
  AIDS; HIV Infections
  
• Safety and Efficacy of the ZoMaxx(TM) Drug-Eluting Stent System in Coronary Arteries
  ClinicalTrials.gov Identifier: NCT00140101 - Recruiting
  Coronary Disease; Coronary Atherosclerosis; Arterial Occlusive Diseases
  
• Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage
  ClinicalTrials.gov Identifier: NCT00405301 - Recruiting
  Drug Induced Hepaotoxicity; Tuberculosis
  
• Drug Interaction Study with NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
  ClinicalTrials.gov Identifier: NCT00032916 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule; Infusions, Intravenous
  
• Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
  ClinicalTrials.gov Identifier: NCT00033007 - Active, not recruiting
  Substance-Related Disorders
  
• Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00076570 - Active, not recruiting
  Kidney Transplantation
  
• Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
  ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
  Hepatitis C, Chronic; Fibrosis
  
• Comparison of Study Drug With Alendronate on How it Effects Glucocorticoid-Induced Osteoporosis
  ClinicalTrials.gov Identifier: NCT00051558 - Active, not recruiting
  Osteoporosis
  
• A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00559884 - Not yet recruiting
  Type 2 Diabetes Mellitus
  
• A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00112437 - Active, not recruiting
  Osteoporosis
  
• A Two Year Investigational Drug Study to Assess Weight Loss in Obese Patients
  ClinicalTrials.gov Identifier: NCT00131391 - Active, not recruiting
  Obesity
  
• GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00044343 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00111891 - Active, not recruiting
  Dyslipidemia
  
• Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00416546 - Recruiting
  Healthy
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• A Comparison Study Between Cefdinir and Amoxicilline/Clavulonate in Patients with Acute Sinusitis and Assessment of Quality of Life
  ClinicalTrials.gov Identifier: NCT00147914 - Active, not recruiting
  Acute bacterial sinusitis
  
• Prometa Pharmacotherapy for Methamphetamine Dependence
  ClinicalTrials.gov Identifier: NCT00260481 - Recruiting
  Drug Abuse; Drug Dependence
  
• Neurological Influences on Drug Prevention Intervention
  ClinicalTrials.gov Identifier: NCT00198939 - Recruiting
  Youths at-Risk for Drug Use/Abuse
  
• Treating the Partners of Drug Using Pregnant Women: Stage II
  ClinicalTrials.gov Identifier: NCT00496990 - Recruiting
  Drug Addiction
  
• Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil
  ClinicalTrials.gov Identifier: NCT00566865 - Recruiting
  Type 2 Diabetes Mellitus
  
• Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812
  ClinicalTrials.gov Identifier: NCT00411866 - Recruiting
  Healthy
  
• Recovery Housing For Drug Dependent Pregnant Women
  ClinicalTrials.gov Identifier: NCT00497302 - Recruiting
  Drug Addiction
  
• Medical Office Intervention for Adolescent Drug Use - 1
  ClinicalTrials.gov Identifier: NCT00229983 - Recruiting
  Alcohol Abuse, Alcohol-Related Disorders; Drug Counseling; Substance-Related Disorders; Alcohol & Drug Use
  
• Safety and Immunogenicity of FluBlok in Pediatrics
  ClinicalTrials.gov Identifier: NCT00336453 - Active, not recruiting
  Influenza
  
• ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects
  ClinicalTrials.gov Identifier: NCT00437775 - Recruiting
  Diabetes Mellitus Type 2
  
• Brief Intervention for Drug Abusing Adolescents
  ClinicalTrials.gov Identifier: NCT00350909 - Recruiting
  Drug Abuse
  
• Safety and Efficacy Study of Hydromorphone and Morphine
  ClinicalTrials.gov Identifier: NCT00195910 - Active, not recruiting
  Pain
  
• Immunogenicity and Safety of Verorab™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00260351 - Active, not recruiting
  Rabies
  
• A Trial to Evaluate the Shedding and Safety of CAIV-T
  ClinicalTrials.gov Identifier: NCT00344305 - Active, not recruiting
  Healthy
  
• Study of Safety and Efficacy of an Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00391807 - Active, not recruiting
  Contraception
  
• MK0974 Long Term Safety Study
  ClinicalTrials.gov Identifier: NCT00443209 - Active, not recruiting
  Migraine
  
• Safety, Blood Levels and Effects of GW642444
  ClinicalTrials.gov Identifier: NCT00469040 - Active, not recruiting
  Asthma
  
• Study of Safety and Efficacy of an Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00477633 - Active, not recruiting
  Contraception
  
• Efficacy and Safety of Grasspollen Sublingual Immunotherapy
  ClinicalTrials.gov Identifier: NCT00567346 - Active, not recruiting
  Rhinoconjunctivitis
  
• Safety and Effectiveness of D-Cycloserine in Children With Autism
  ClinicalTrials.gov Identifier: NCT00198120 - Active, not recruiting
  Autistic Disorder
  
• Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine
  ClinicalTrials.gov Identifier: NCT00258830 - Active, not recruiting
  Influenza
  
• Safety of Imovax Polio in Chinese Infants and Children
  ClinicalTrials.gov Identifier: NCT00258843 - Active, not recruiting
  Poliomyelitis
  
• Immunogenicity and Safety of ADACEL™ in Taiwan
  ClinicalTrials.gov Identifier: NCT00258908 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Safety and Efficacy of Exenatide as Monotherapy
  ClinicalTrials.gov Identifier: NCT00381342 - Active, not recruiting
  Type 2 Diabetes Mellitus